Overview

Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo

Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
A non-fission sourced, solvent generator produced 99mTc intravenous injection, as 99mTc -MDP, is to be used as a bone scan diagnostic radiopharmaceutical for assessment of bone pathology using the same oncologic indications as nuclear reactor sourced 99mTc, as 99mTc-MDP.
Phase:
Phase 3
Details
Lead Sponsor:
University of Manitoba
Collaborator:
Winnipeg Regional Health Authority
Treatments:
Sodium Pertechnetate Tc 99m
Technetium Tc 99m Medronate